Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
BioAtla, Inc. Financials Banner

BioAtla, Inc. Financials

BCAB Stock Analysis

Page title

Section title

BCAB Income Statement Key Metrics

  • Revenue(TTM)12.71 M
  • Gross Profit(TTM)11.87 M
  • EBITDA(TTM)-85.40 M
  • Net Income(TTM)-81.82 M
  • EPS Diluted(TTM)-1.7000000000000002

Decode BCAB's Latest Earnings Call with Ease

Tap 'Generate' for a crystal-clear,
AI-crafted summary and stay ahead in the investment game!

BCAB earnings and revenue history

BCAB Return on Equity

See how efficiently BCAB generates profit for it's shareholders.

-174.70%

10
0
100
  1. Poor

  2. Average

  3. Strong

Return on Equity vs Peers

Return on Equity ratio of BCAB (-1.747) is lower than the average of its peers (-0.372).

Return on Equity Growth

BCAB's Return on Equity has shown poor growth over the past 10 years, increasing by only -9.42%.

BCAB Revenue Growth

See how BCAB has grown it's revenue over the past 10 years.


Revenue Growth

BCAB's revenue has shown poor growth over the past 10 years, increasing by only -100%.

BCAB FY, 2023 Revenue Breakdown

See how BCAB converts it's revenue into profit.

BCAB Balance Sheet Health

BCAB Balance Sheet Breakdown 2023

Assets

  1. Long Term Assets

  2. Cash & Equivalents

  3. Inventory

  4. Receivables

  5. Property Plant Equipments

  6. Others

Liabilities

  1. Short Term Debt

  2. Long Term Debt

  3. Account Payables

  4. Others

BCAB financial position analysis

Short Term Liabilities

BCAB's short term assets($116M) can safely cover it's short term liabilities($28M).

Long Term Liabilities

BCAB's short term assets($116M) can safely cover it's long term liabilities($21M).

BCAB Debt to Equity